Last update 02 May 2024
CARsgen Therapeutics Co.,Ltd

CARsgen Therapeutics Co.,Ltd

Subsidiary Company|
2014|
Shanghai Shi, China
|
500-1,000
| HKG: 02171.HK|

Overview

Basic Info

Introduction
CARsgen is a prominent immunotherapy company that specializes in creating innovative chimeric antigen receptor T (CAR-T) cell therapies for the treatment of liver, lung, stomach, and brain cancers. The company has collaborations with Shanghai Cancer Institute and Shanghai Renji Hospital. CARsgen is at the forefront of CAR-T development, having successfully completed the world's first hepatocellular carcinoma (HCC) and China's exclusive glioblastoma multiforme (GBM) dose ascending injection tests. With funding from BVCF, a top venture capital firm, CARsgen is well-positioned to introduce a new cancer treatment to the market in China and globally.

Tags

Neoplasms
Digestive System Disorders
Hemic and Lymphatic Diseases
CAR-T
Monoclonal antibody
T-lymphocyte cell therapy

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
CAR-T10
Gene therapy1
Autologous CAR-T1
T-lymphocyte cell therapy1
Monoclonal antibody1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 May 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
3
6
Phase 1 Clinical
Phase 2 Clinical
3
1
NDA/BLA
Other
1
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free